Locus 139: SPTLC3 (20p12.1)
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs4814176 |
| Chromosomal location | Chr20: 12,907,398 (20p12.1) |
| Gene (distance) | SPTLC3 (-30,228) |
| Predicted causal gene | SPTLC3 |
| Gene/protein classification | - |
| Metabolite (Pathway) | X-10510 (Unknown) palmitoyl sphingomyelin (Sphingolipid; Lipid) |
| Biochemical locus-metabolite relationship | SPTLC3 encodes a subunit of serine palmitoyltransferase [17023427]. SPT is the first step in de novo sphingolipid biosynthesis. Ratio interpretation: n/a. |
| eQTL associations | SPTLC3 (H) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | Sphingolipid levels [22359512,19798445]; SM (OH) C24:1/SM C16:0 [20037589] |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

